Seeking Alpha

Pfizer's (PFE -0.2%) Viagra patent has been ruled no longer valid by Canada's top court, backing...

Pfizer's (PFE -0.2%) Viagra patent has been ruled no longer valid by Canada's top court, backing an appeal by generic drug maker Teva Pharmaceutical (TEVA +0.1%) that claimed PFE hadn't provided sufficient details when it initially filed its patent registration.
Comments (1)
  • taplinger
    , contributor
    Comments (196) | Send Message
     
    Was it the current CEO that made the decision to withhold the active ingredient or was it someone in senior management? It would be nice to have accountability. This is the kind of thing that gives pharmaceuticals a bad name.
    9 Nov 2012, 12:47 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|